Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial.

Autor: Tartaglione G; From the *Department of Nuclear Medicine, Cristo Re Hospital, Rome, Italy; †Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St Gallen, St Gallen, Switzerland; ‡Department of Head and Neck Surgical Oncology, UMCU Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands; §Department of Head and Neck Surgery, Guys and St Thomas NHS Trust, London, UK; ∥Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark; ¶Department of Otolaryngology-Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark; **Department of Head and Neck Surgery, CHU Dinant Godinne, Université Catholique de Louvain, Belgium; ††Department of Maxillofacial Surgery, CHU de Charleroi Belgium, Belgium; ‡‡Department of Maxillofacial Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain; §§Department of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain; ∥∥Department of Maxillofacial Surgery, BioCruces, Hospital Universitario De Cruces, Universidad del Pais Vasco (UPV/EHU), Bilbao, Spain; ¶¶Department of Head and Neck Surgery, Instituto Portugues de Oncologia do Porto, Portugal; ***Department of Maxillofacial Surgery, Azienda Ospedaliera, Universitaria di Parma, Parma, Italy; †††Department of Otolaryngology, Ospedale S. Chiara, Trento, Italy; ‡‡‡Department of Otorhinolaryngology, San Carlo Hospital, Rome, Italy; §§§Department of Nuclear Medicine, Guys and St Thomas NHS Trust, London, UK; ∥∥∥Department of Nuclear Medicine, Ospedale S. Chiara, Trento, Italy; ¶¶¶Department of Pathology, VU University Medical Centre and Academic Centre of Dentistry Amsterdam, Amsterdam, The Netherlands; ****Pathology Centre, Queen Alexandra Hospital, Portsmouth, UK; ††††Department of Head and Neck Surgery, University of Basel, Basel, Switzerland; ‡‡‡‡Department of Otolaryngology, University Hospital Zurich, Zurich, Switzerland; §§§§Dep, Stoeckli SJ, de Bree R, Schilling C, Flach GB, Bakholdt V, Sorensen JA, Bilde A, von Buchwald C, Lawson G, Dequanter D, Villarreal PM, Forcelledo MF, Amezaga JA, Moreira A, Poli T, Grandi C, Vigili MG, O'Doherty M, Donner D, Bloemena E, Rahimi S, Gurney B, Haerle SK, Broglie MA, Huber GF, Krogdah AL, Sebbesen LR, Odell E, Junquera Gutierrez LM, Barbier L, Santamaria-Zuazua J, Jacome M, Nollevaux MC, Bragantini E, Lothaire P, Silini EM, Sesenna E, Dolivet G, Mastronicola R, Leroux A, Sassoon I, Sloan P, Colletti PM, Rubello D, McGurk M

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2016 Jul; Vol. 41 (7), pp. 534-42.